Susan Montgomery / Shutterstock.com
Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta (pemetrexed disodium).
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Eli Lilly; patent infringement, English High Court;